Literature DB >> 10446202

Phosphoinositide 3-OH kinase (PI3K) and PKB/Akt delay the onset of p53-mediated, transcriptionally dependent apoptosis.

P Sabbatini1, F McCormick.   

Abstract

The phosphoinositide 3-OH kinase (PI3K)-PKB/Akt signaling pathway has been shown to mediate both Ras- and cytokine-induced protection from apoptosis. In addition, apoptosis induced by the p53 tumor suppressor protein can be inhibited by Ras- and cytokine-mediated signaling pathways. It was therefore of interest to determine if the PI3K-PKB/Akt signaling pathway was capable of conferring protection from apoptosis induced by p53. We demonstrate in this report that constitutively active PI3K and PKB/Akt are capable of significantly delaying the onset of p53-mediated apoptosis. This was manifested as a delay in the kinetics of DNA degradation and cell death as well as a profound attenuation in the accumulation of cells with a sub-G(1) DNA content. Moreover, we found that this effect is mediated in the absence of changes in expression of Bcl-2, Bcl-Xl, and the pro-apoptotic protein Bax. Our results provide the first direct and unambiguous link between p53-mediated apoptosis and the PI3K-PKB/Akt signaling pathway.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10446202     DOI: 10.1074/jbc.274.34.24263

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

Review 1.  Protein kinases as therapeutic targets.

Authors:  R Sridhar; O Hanson-Painton; D R Cooper
Journal:  Pharm Res       Date:  2000-11       Impact factor: 4.200

Review 2.  Phosphatidylinositol 3' kinase signaling in mammary tumorigenesis.

Authors:  M P Scheid; J R Woodgett
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-01       Impact factor: 2.673

3.  Relationship and prognostic significance of phospho-(serine 166)-murine double minute 2 and Akt activation in node-negative breast cancer with regard to p53 expression.

Authors:  K J Schmitz; F Grabellus; R Callies; J Wohlschlaeger; F Otterbach; R Kimmig; B Levkau; K W Schmid; H A Baba
Journal:  Virchows Arch       Date:  2005-10-06       Impact factor: 4.064

4.  MOZ increases p53 acetylation and premature senescence through its complex formation with PML.

Authors:  Susumu Rokudai; Oleg Laptenko; Suzzette M Arnal; Yoichi Taya; Issay Kitabayashi; Carol Prives
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-19       Impact factor: 11.205

5.  Modeling the response of a tumor-suppressive network to mitogenic and oncogenic signals.

Authors:  Xinyu Tian; Bo Huang; Xiao-Peng Zhang; Mingyang Lu; Feng Liu; José N Onuchic; Wei Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-08       Impact factor: 11.205

6.  Redefining the roles of apoptotic factors in carcinogenesis.

Authors:  Xinjian Liu; Yujun He; Fang Li; Qian Huang; Takamitsu A Kato; Russell P Hall; Chuan-Yuan Li
Journal:  Mol Cell Oncol       Date:  2015-06-10

Review 7.  The roles of K(+) channels in cancer.

Authors:  Luis A Pardo; Walter Stühmer
Journal:  Nat Rev Cancer       Date:  2013-12-12       Impact factor: 60.716

8.  G Protein-Coupled Receptor 87: a Promising Opportunity for Cancer Drug Discovery.

Authors:  Yanhong Zhang; Ariane Scoumanne; Xinbin Chen
Journal:  Mol Cell Pharmacol       Date:  2010-01-01

9.  Accumulation of cytoplasmic beta-catenin and nuclear glycogen synthase kinase 3beta in Epstein-Barr virus-infected cells.

Authors:  David N Everly; Shuichi Kusano; Nancy Raab-Traub
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

10.  Growth inhibition of non-small-cell lung carcinoma by BN/GRP antagonist is linked with suppression of K-Ras, COX-2, and pAkt.

Authors:  Florian Hohla; Andrew V Schally; Celia A Kanashiro; Stefan Buchholz; Benjamin Baker; Chandrika Kannadka; Angelika Moder; Elmar Aigner; Christian Datz; Gabor Halmos
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.